AeroLeads people directory · profile

Clay Beauregard Email & Phone Number

Senior Director, Program Team Leader at Calico Life Sciences
Location: Dallas, Texas, United States 8 work roles 3 schools
LinkedIn matched
✓ Verified Jun 2026 3 data sources Profile completeness 86%

Contact Signals

LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Calico Life Sciences
Role
Senior Director, Program Team Leader
Location
Dallas, Texas, United States
Company size
45 employees

Who is Clay Beauregard? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Clay Beauregard is listed as Senior Director, Program Team Leader at Calico Life Sciences, a company with 45 employees, based in Dallas, Texas, United States. AeroLeads shows a matched LinkedIn profile for Clay Beauregard.

Clay Beauregard previously worked as Program Strategy Consultant at Shape Therapeutics Inc. and Vice President, Program Executive at Vir Biotechnology, Inc.. Clay Beauregard holds Master Of Science (M.S.), Marine Biology from Nova Southeastern University.

Company email context

Email format at Calico Life Sciences

This section adds company-level context without repeating Clay Beauregard's masked contact details.

Calico Life Sciences

Review company-level records connected to Clay Beauregard before choosing the right outreach path.

View email format View company profile Management contacts
Profile bio

About Clay Beauregard

I was the Program Executive for the viral-vectored vaccine program at Vir Biotechnology for 2.5 years, leading development of VIR-1388 for HIV prevention in partnership with the Gates Foundation, NIAID/DAIDS, and the HIV Vaccine Trials Network. I was also responsible for preclinical programs in TB, HPV neoplasia and HIV therapeutics.Prior to joining Vir, I was a Project Team Leader at Calico, leading all oncology and IO programs in the Calico-AbbVie collaboration, including the ongoing clinical studies of two oral small molecule PTPN2 inhibitors, ABBV-CLS-579 and ABBV-CLS-484, discovered in partnership with the Broad Institute. I also led several discovery programs in the targeted degrader space partnered with C4 Therapeutics.At the Baylor Institute for Immunology Research, I led the Center for Therapeutic Development, responsible for bringing the institute's novel discoveries into clinical development through partnerships and strategic collaborations. As a major highlight, I was a co-founder of the spinoff company, Denceptor Therapeutics, a joint venture between Baylor and the UK-based CRO, Abzena.My early career was focused on understanding transplant immunology and mechanisms of corneal allograft rejection through postdoctoral fellowships at the Schepens Eye Research Institute of Harvard and at UT-Southwestern, followed by tenure as a Principal Scientist at Alcon Labs where I led a biology lab in ophthalmic allergy and inflammation and served as research representative or numerous development core teams.

Current workplace

Clay Beauregard's current company

Company context helps verify the profile and gives searchers a useful next step.

Calico Life Sciences
Calico Life Sciences
Senior Director, Program Team Leader
Burlingame, CA, US
Website
shapetx.com
Employees
45
AeroLeads page
Company profile
View company profile Email format
8 roles · 25 years

Clay Beauregard work experience

A career timeline built from the work history available for this profile.

Program Strategy Consultant

Current
Shape Therapeutics Inc.

Seattle, Washington, United States

Expert consultant on early development strategy for Shape’s novel RNA editing candidates. Working with the Head of Operations, helped manage the cross-functional Early Development Team and develop a go-to-IND strategy.

Jul 2024 - Present

Vice President, Program Executive

Vir Biotechnology, Inc.

San Francisco, California, United States

  • Reporting to the EVP/Head of Product Development, the Program Executive is the key accountable person within the company for formulating and implementing the integrated program strategy
  • Led a large cross-functional program team developing hCMV-vectored vaccines for prevention of HIV and TB and for treatment of HPV-driven neoplasia
  • Delivered VIR-1388 (HIV vaccine) from candidate nomination into first-in-human study in US and South Africa, in partnership with Gates Foundation, HIV Vaccine Trials Network, and NIH/NIAID/DAIDS
  • Development lead for early stage HIV broadly neutralizing antibody discovery program
  • Joint Steering Committee member for multiple key partnerships
Aug 2021 - Jan 2024

Project Team Leader

Calico Labs

San Francisco Bay Area

  • Reporting to the Head of Project Team Leadership, I led cross-functional project teams of both Calico and AbbVie functional experts and was the single point of accountability for all project-related strategy and.
  • Delivered ABBV-CLS-579 and ABBV-CLS-484, two novel oral small molecule inhibitors of PTPN2, from pre-candidate nomination into first in human trials for oncology
  • In addition to the lead PTPN2 program, I led a joint 3-way project team with Calico, AbbVie and C4 Therapeutics to discover and develop novel targeted protein degraders for several oncology targets
  • Led a research project team with Calico and the Broad Institute to discover novel drug targets using the TIDE (tumor immunology discovery engine) platform
Apr 2017 - Aug 2021

Director Of Therapeutic Development, Baylor Institute For Immunology Research

Baylor Scott & White Research Institute

Dallas/Fort Worth Area

  • Reporting to CSO, led formation of the new Center for Therapeutic Development and helped re-organize BIIR into an industry-like program team structure, bringing together PI’s, core labs, and clinician-scientists.
  • Accountable for operational success of nonclinical IND-enabling studies (humanization, cell line development, cGMP manufacturing, GLP safety assessment) for multiple mAb programs
  • Scientific co-founder and part of the virtual management team of Denceptor Therapeutics, a spinoff company jointly formed by Baylor and Abzena, a UK-based CRO.
  • Alliance director for multi-year discovery and development collaborations with Roche, Pfizer and INSERM
  • Supported business development, IP strategy, grant submissions, fundraising, and community outreach
May 2012 - Apr 2017

Principal Scientist

Alcon Laboratories, Inc.

Dallas/Fort Worth Area

  • Head of a drug discovery lab focused on pharmacological characterization of small molecules for inflammation, allergy, and autoimmunity of the eye and respiratory tract
  • Responsible for recommendation of research gating decisions to R&D governance bodies
  • Contributed to IND submissions as the Research function representative on development Core teams
  • Scientific due diligence for in-licensing opportunities
  • Line management and mentoring of PhD and non-PhD scientists
  • Promoted from Sr. Scientist II to Sr. Scientist III to Principal Scientist during my tenure
Feb 2005 - Mar 2012
Team & coworkers

Colleagues at Calico Life Sciences

Other employees you can reach at shapetx.com. View company contacts for 45 employees →

MM Marsha Mason (She, Her, Hers) Marsha Mason (She, Her, Hers) Colleague at Calico Life SciencesSeattle, Washington, United States, United States View → JB Jeremy Bazinet Jeremy Bazinet Colleague at Calico Life SciencesSeattle, Washington, United States, United States View → AB Ashley Benson Ashley Benson Colleague at Calico Life SciencesGreater Seattle Area, United States View → JT Jacob Tome Jacob Tome Colleague at Calico Life SciencesSeattle, Washington, United States, United States View → JH Jana Henry (Krieg) Jana Henry (Krieg) Colleague at Calico Life SciencesSeattle, Washington, United States, United States View → RR Renuka Ramanathan, Phd Renuka Ramanathan, Phd Colleague at Calico Life SciencesUnited States, United States View → LK Lisa Keane Lisa Keane Colleague at Calico Life SciencesGreater Seattle Area, United States View → WJ William Johnsen William Johnsen Colleague at Calico Life SciencesSeattle, Washington, United States, United States View → E( Edward (Ted) Gniffke Edward (Ted) Gniffke Colleague at Calico Life SciencesSeattle, Washington, United States, United States View → AL Anupama Lakshmanan Anupama Lakshmanan Colleague at Calico Life SciencesSeattle, Washington, United States, United States View →
3 education records

Clay Beauregard education

FAQ

Frequently asked questions about Clay Beauregard

Quick answers generated from the profile data available on this page.

What company does Clay Beauregard work for?

Clay Beauregard works for Calico Life Sciences.

What is Clay Beauregard's role at Calico Life Sciences?

Clay Beauregard is listed as Senior Director, Program Team Leader at Calico Life Sciences.

Where is Clay Beauregard based?

Clay Beauregard is based in Dallas, Texas, United States while working with Calico Life Sciences.

What companies has Clay Beauregard worked for?

Clay Beauregard has worked for Calico Life Sciences, Shape Therapeutics Inc., Vir Biotechnology, Inc., Calico Labs, and Baylor Scott & White Research Institute.

Who are Clay Beauregard's colleagues at Calico Life Sciences?

Clay Beauregard's colleagues at Calico Life Sciences include Marsha Mason (She, Her, Hers), Jeremy Bazinet, Ashley Benson, Jacob Tome, and Jana Henry (Krieg).

How can I contact Clay Beauregard?

You can use AeroLeads to view verified contact signals for Clay Beauregard at Calico Life Sciences, including work email, phone, and LinkedIn data when available.

What schools did Clay Beauregard attend?

Clay Beauregard holds Master Of Science (M.S.), Marine Biology from Nova Southeastern University.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.